Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Archivos de la Sociedad Española de Oftalmología
versión impresa ISSN 0365-6691
Resumen
GOMEZ LEDESMA, I.; SANTIAGO RODRIGUEZ, M.Á. de; FOLLANA NEIRA, I. y LEON GARRIGOSA, F.. Neovascular membrane and pregnancy: Treatment with bevacizumab. Arch Soc Esp Oftalmol [online]. 2012, vol.87, n.9, pp.297-300. ISSN 0365-6691. https://dx.doi.org/10.1016/j.oftal.2011.09.011.
Clinical case: Female in her sixth month of pregnancy, with a history of refractive surgery, who consulted due to a metamorphopsia and decrease in visual acuity in the right eye. A presumed ocular histoplasmosis syndrome (POHS) and a subfoveal choroidal neovascular membrane were observed in the fundoscopy. Two monthly doses of intravitreal bevacizumab were given after the labour, but the third dose was never inyected as the patient became pregnant again. She subsequently had a spontaneous miscarriage. Discussion: Treatment with intravitreal bevacizumab during pregnancy is controversial as it may increase the risk of miscarriage during the first trimester.
Palabras clave : Bevacizumab; Intravitreal injections; Choroidal neovascularisation; Miscarriage; Pregnancy.